These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 33754440)

  • 21. Combination of pre-adapted bacteriophage therapy and antibiotics for treatment of fracture-related infection due to pandrug-resistant Klebsiella pneumoniae.
    Eskenazi A; Lood C; Wubbolts J; Hites M; Balarjishvili N; Leshkasheli L; Askilashvili L; Kvachadze L; van Noort V; Wagemans J; Jayankura M; Chanishvili N; de Boer M; Nibbering P; Kutateladze M; Lavigne R; Merabishvili M; Pirnay JP
    Nat Commun; 2022 Jan; 13(1):302. PubMed ID: 35042848
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New Bacteriophages against Emerging Lineages ST23 and ST258 of
    Thiry D; Passet V; Danis-Wlodarczyk K; Lood C; Wagemans J; De Sordi L; van Noort V; Dufour N; Debarbieux L; Mainil JG; Brisse S; Lavigne R
    Viruses; 2019 May; 11(5):. PubMed ID: 31058805
    [No Abstract]   [Full Text] [Related]  

  • 23. Biological characteristics and genome analysis of a novel phage vB_KpnP_IME279 infecting Klebsiella pneumoniae.
    Zhang R; Zhao F; Wang J; Pei G; Fan H; Zhangxiang L; Mi Z; Shi T; Liu H; Tong Y
    Folia Microbiol (Praha); 2020 Dec; 65(6):925-936. PubMed ID: 33064268
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Isolation and characterization of lytic phage TUN1 specific for Klebsiella pneumoniae K64 clinical isolates from Tunisia.
    Eckstein S; Stender J; Mzoughi S; Vogele K; Kühn J; Friese D; Bugert C; Handrick S; Ferjani M; Wölfel R; Millard A; Ben Moussa M; Bugert JJ
    BMC Microbiol; 2021 Jun; 21(1):186. PubMed ID: 34154528
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diversity of mucoid to non-mucoid switch among carbapenemase-producing Klebsiella pneumoniae.
    Chiarelli A; Cabanel N; Rosinski-Chupin I; Zongo PD; Naas T; Bonnin RA; Glaser P
    BMC Microbiol; 2020 Oct; 20(1):325. PubMed ID: 33109078
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genomic Diversity, Virulence, and Antimicrobial Resistance of
    Yang Y; Higgins CH; Rehman I; Galvao KN; Brito IL; Bicalho ML; Song J; Wang H; Bicalho RC
    Appl Environ Microbiol; 2019 Mar; 85(6):. PubMed ID: 30610074
    [No Abstract]   [Full Text] [Related]  

  • 27. Evaluation of the efficacy of a bacteriophage in the treatment of pneumonia induced by multidrug resistance Klebsiella pneumoniae in mice.
    Cao F; Wang X; Wang L; Li Z; Che J; Wang L; Li X; Cao Z; Zhang J; Jin L; Xu Y
    Biomed Res Int; 2015; 2015():752930. PubMed ID: 25879036
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phage therapy for treatment of virulent Klebsiella pneumoniae infection in a mouse model.
    Anand T; Virmani N; Kumar S; Mohanty AK; Pavulraj S; Bera BC; Vaid RK; Ahlawat U; Tripathi BN
    J Glob Antimicrob Resist; 2020 Jun; 21():34-41. PubMed ID: 31604128
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fitness Trade-Offs Resulting from Bacteriophage Resistance Potentiate Synergistic Antibacterial Strategies.
    Mangalea MR; Duerkop BA
    Infect Immun; 2020 Jun; 88(7):. PubMed ID: 32094257
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of antibiotic resistance in bacteriophage-insensitive Klebsiella pneumoniae.
    Uddin MJ; Kim B; Dawan J; Ding T; Kim JC; Ahn J
    Microb Pathog; 2019 Oct; 135():103625. PubMed ID: 31325570
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heterogeneous
    Qin J; Wu N; Bao J; Shi X; Ou H; Ye S; Zhao W; Wei Z; Cai J; Li L; Guo M; Weng J; Lu H; Tan D; Zhang J; Huang Q; Zhu Z; Shi Y; Hu C; Guo X; Zhu T
    Front Cell Infect Microbiol; 2020; 10():608402. PubMed ID: 33569355
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Global Trends in Proteome Remodeling of the Outer Membrane Modulate Antimicrobial Permeability in Klebsiella pneumoniae.
    Rocker A; Lacey JA; Belousoff MJ; Wilksch JJ; Strugnell RA; Davies MR; Lithgow T
    mBio; 2020 Apr; 11(2):. PubMed ID: 32291303
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Emergence of the Novel Aminoglycoside Acetyltransferase Variant
    Sato T; Wada T; Nishijima S; Fukushima Y; Nakajima C; Suzuki Y; Takahashi S; Yokota SI
    mBio; 2020 Dec; 11(6):. PubMed ID: 33443109
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PhREEPred: Phage Resistance Emergence Prediction Web Tool to Foresee Encapsulated Bacterial Escape from Phage Cocktail Treatment.
    Smug BJ; Majkowska-Skrobek G; Drulis-Kawa Z
    J Mol Biol; 2022 Jul; 434(14):167670. PubMed ID: 35671831
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recombinant Reporter Phage rTUN1::
    Braun P; Raab R; Bugert JJ; Braun S
    ACS Sens; 2023 Feb; 8(2):630-639. PubMed ID: 36719711
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The therapeutic potential of bacteriophages targeting gram-negative bacteria using Galleria mellonella infection model.
    Manohar P; Nachimuthu R; Lopes BS
    BMC Microbiol; 2018 Aug; 18(1):97. PubMed ID: 30170558
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhanced Antibacterial Activity of Repurposed Mitomycin C and Imipenem in Combination with the Lytic Phage vB_KpnM-VAC13 against Clinical Isolates of Klebsiella pneumoniae.
    Pacios O; Fernández-García L; Bleriot I; Blasco L; González-Bardanca M; López M; Fernández-Cuenca F; Oteo J; Pascual Á; Martínez-Martínez L; Domingo-Calap P; Bou G; Tomás M;
    Antimicrob Agents Chemother; 2021 Aug; 65(9):e0090021. PubMed ID: 34228538
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-active antibiotic and bacteriophage synergism to successfully treat recurrent urinary tract infection caused by extensively drug-resistant
    Bao J; Wu N; Zeng Y; Chen L; Li L; Yang L; Zhang Y; Guo M; Li L; Li J; Tan D; Cheng M; Gu J; Qin J; Liu J; Li S; Pan G; Jin X; Yao B; Guo X; Zhu T; Le S
    Emerg Microbes Infect; 2020 Dec; 9(1):771-774. PubMed ID: 32212918
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of the therapeutic potential of bacteriophage KpV74 and phage-derived depolymerase (β-glucosidase) against Klebsiella pneumoniae capsular type K2.
    Volozhantsev NV; Borzilov AI; Shpirt AM; Krasilnikova VM; Verevkin VV; Denisenko EA; Kombarova TI; Shashkov AS; Knirel YA; Dyatlov IA
    Virus Res; 2022 Dec; 322():198951. PubMed ID: 36191686
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fighting Pathogenic Bacteria on Two Fronts: Phages and Antibiotics as Combined Strategy.
    Tagliaferri TL; Jansen M; Horz HP
    Front Cell Infect Microbiol; 2019; 9():22. PubMed ID: 30834237
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.